Correlation between Inflammatory Biomarkers and Red Blood Cell Life Span in Chronic Hemodialysis Patients
Jie Ma(Renal Research Institute), Peter Kotanko(Renal Research Institute), Hanjie Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuedong Wang(University of California, Santa Barbara), Stephan Thijssen, Michelle MY Wong(Renal Research Institute), Vanja Peršič(Renal Research Institute), Yanna Dou(First Affiliated Hospital of Zhengzhou University), Nathan W. Levin(Renal Research Institute), Laura Rosales, Viktoriya Kuntsevich(Icahn School of Medicine at Mount Sinai), Georges Ouellet(Hôpital Maisonneuve-Rosemont), Anja Kruse
Cited by 41
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Body fluid volume determination via body composition spectroscopy in health and disease
|Physiological Measurement|2006|608
The burden of kidney disease: Improving global outcomes
|Kidney International|2004|521
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2019|425
Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease
|Annals of Internal Medicine|2005|323